ML20154F409

Requests Addl Info Re Greening Training & Experience,To Continue NRC Review of 851125 Application for Amend to License 50-17686-01

ML20154F409
Person / Time
Site:	03013158
Issue date:	12/10/1985
From:	Riedlinger B NRC OFFICE OF INSPECTION & ENFORCEMENT (IE REGION V)
To:	Burns J BARTLETT MEMORIAL HOSP., JUNEAU, AK
Shared Package
ML20154F297	List: ML20154F292 ML20154F310 ML20154F359 ML20154F409
References
70299, NUDOCS 8603070454
Download: ML20154F409 (2)

See also: IR 05000176/1986001

Text

r

• ,

'

-

- .

.

..

.

5a DEC 10 W

Docket No. : 030-13158

Licende No.: 50-17686-01

Control No.: 70299

Bartlett Memorial Hospital

3260 Hospital Drive

Juneau, Alaska 99801

Attention: Mr. James R. Burns

Administrator

Gentlemen:

This is in reference to your application dated November 25, 1985 to amend your

byproduct material license. In order to complete our review, we need the

following additional information:

1. You should submit documentation that Dr. Greening has completed 200

hours of didactic training as described in Item 2.a. of Appendix A to

Regulatory Guide 8.20. Although the Supplement A which was submitted

with your letter dated November 25, 1985 does indicate that Dr. Greening

received training at the Hospital of the University of Pennsylvania, it

does not reflect the number of hours of didactic training received in

each of the five fields of training indicated on Supplement A.

,

2. Although the NRC-313M Supplement B lists three hospitals where Dr.

Greening received training and experience, only one preceptor signature

is given. Separate preceptor statements should be submitted from each

institution. These statements should indicate the extent of Dr.

Greening's involvement with the nuclear medicine programs. Refer to

Item 2.c. of Appendix A to Regulatory Guide 10.8,

If it is not possible to obtain preceptor statements from physicians who

supervised Dr. Greening during his internship, you should ask that each

of the three hospitals submit a signed statement to document:

a. the time interval when Dr. Greening was present at the f acility.

b. his involvement with the nuclear medicine program.

c. the extent of his involvement (patient selection, dose

determination, scan interpretation, patient followup, study of

possible complications, etc.)

d. any authorization granted to Dr. Greening by the hospital's

, ,

ames) . . . .R.V .

gg , [ . . g. . .m . m o0603070454

.

............ m . m . . b....,m--.mlmm.

060203

l "'"""""'" " " * " " " " " " " " " " " " * " " " " " '

• • ME) REG 5 LIC30 **************** '" " " **" " "'**** " "***"'**********

.................. .................

o- 06-oi PDR

our) . ..12. ./.[Q . ./.8. 5.. .

.....................l.....................l.....................l............................................................

---

a = a m a n . aru na me na n u n n E" E" I t'* l A I D E*(* M D r) (* O PY  % U.S. GPO 1983-400-243

.

J'

.

Bartlett Memorial Hospital -2- DEC 101905

3. In order to add Dr. Greening as an authorized user for Group III, we

must have documentation to verify that he has personally participated in

five procedures to elute technetium-99m including testing of elute,

and in five procedures to prepare radiopharmaceuticals from Group III

reagent kits. You should submit this documentation. Refer to Item 2b

of Appendix A to Regulatory Guide 10.8.

We will continue the review.uf your amendment request upon receipt of this

information. If we do not receive a reply from you within 30 calendar days

from the date of this letter, we shall assume that you do not wish to pursue

your application. Please reply in duplicate, and refer to Mail Control No.

70299.

Sincerely,

Beth A. Riedlinger

Health Physicist (Licensing)

Nuclear Materials Safety Section

Enclosures:

Appendix A to Regulatory Guide 10.8

Federal Register Notice dated December 2, 1982 (FR 54376)

NRC Form 313M

t